Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 5(79), p. 863-871
DOI: 10.1007/s00280-017-3279-8
Links
Tools
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
Journal article published in 2017 by
Andrea Rocca,
Lorenzo Cecconetto,
Alessandro Passardi,
Elisabetta Melegari,
Daniele Andreis 
,
Manuela Monti,
Roberta Maltoni,
Samanta Sarti,
Elisabetta Pietri,
Alessio Schirone,
Francesco Fabbri,
Caterina Donati,
Oriana Nanni,
Anna Fedeli,
Marina Faedi
and other authors.
,
Manuela Monti,
Roberta Maltoni,
Samanta Sarti,
Elisabetta Pietri,
Alessio Schirone,
Francesco Fabbri,
Caterina Donati,
Oriana Nanni,
Anna Fedeli,
Marina Faedi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 